BMO On Abbott Labs: 'It's Likely Time For The Stock To Take A Pause' By: Benzinga via Benzinga March 14, 2017 at 12:08 PM EDT BMO downgrades Abbott Laboratories (NYSE: ABT) to Market Perform from Outperform as shares are trading near the brokerage’s $48 ... Read More >> Related Stocks: Abbott Laboratories Baxter International Edwards Lifesciences